Off Target Effects of the Atypical Antipsychotic Clozapine Associated with Increased Infection Risk

Explore the off-target effects of clozapine, an atypical antipsychotic medication, and its association with increased infection risk in this 31-minute webinar presented by Dr. Georgios Miliotis. Delve into the growing recognition of antipsychotic medications' link to heightened infection risks, with a particular focus on clozapine, which is used to treat treatment-resistant schizophrenia. Learn about Dr. Miliotis' background as an Assistant Professor in Bacteriology and member of the Antimicrobial Resistance and Microbial Ecology Group. Gain insights into the specific concerns surrounding respiratory infections in patients treated with clozapine and understand the implications for clinical practice and patient care.

Off Target Effects of the Atypical Antipsychotic Clozapine Associated with Increased Infection Risk